ID   Jurkat clone A3
AC   CVCL_1061
SY   A3
DR   BTO; BTO:0001342
DR   CLO; CLO_0001577
DR   ATCC; CRL-2570
DR   BCRC; 60485
DR   BioSample; SAMN03471678
DR   cancercelllines; CVCL_1061
DR   CCRID; 3101HUMTCHu96
DR   Cell_Model_Passport; SIDM01243
DR   CLS; 305143
DR   GEO; GSM5137705
DR   KCB; KCB 2010084YJ
DR   LINCS_LDP; LCL-1026
DR   MetaboLights; MTBLS226
DR   PRIDE; PXD023662
DR   Wikidata; Q54606726
RX   PubMed=8972182;
RX   PubMed=10616904;
RX   PubMed=35354797;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Metabolome analysis.
CC   Omics: Deep quantitative proteome analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 9
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 29
//
RX   PubMed=8972182; DOI=10.1128/mcb.17.1.24;
RA   Juo P., Kuo C.J., Reynolds S.E., Konz R.F., Raingeaud J., Davis R.J.,
RA   Biemann H.-P., Blenis J.;
RT   "Fas activation of the p38 mitogen-activated protein kinase signalling
RT   pathway requires ICE/CED-3 family proteases.";
RL   Mol. Cell. Biol. 17:24-35(1997).
//
RX   PubMed=10616904;
RA   Juo P., Woo M.S.-A., Kuo C.J., Signorelli P., Biemann H.-P.,
RA   Hannun Y.A., Blenis J.;
RT   "FADD is required for multiple signaling events downstream of the
RT   receptor Fas.";
RL   Cell Growth Differ. 10:797-804(1999).
//
RX   PubMed=35354797; DOI=10.1038/s41467-022-29224-5;
RA   Leo I.R., Aswad L., Stahl M., Kunold E., Post F., Erkers T.,
RA   Struyf N., Mermelekas G., Joshi R.N., Gracia-Villacampa E.,
RA   Ostling P., Kallioniemi O.-P., Pokrovskaja Tamm K., Siavelis I.,
RA   Lehtio J., Vesterlund M., Jafari R.;
RT   "Integrative multi-omics and drug response profiling of childhood
RT   acute lymphoblastic leukemia cell lines.";
RL   Nat. Commun. 13:1691.1-1691.19(2022).
//